Last Day: Watch the Replay of Great Indian Wealth Project Special Event
Here is the latest financial fact sheet of ALEMBIC. For more details, see the ALEMBIC quarterly results and ALEMBIC share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -0.9 |
No. of shares | m | 553.80 |
% ch week | % | 1.2 |
% ch 1-mth | % | 6.3 |
% ch 12-mth | % | 102.7 |
52 week H/L | Rs | 122.8/25.0 |
No. of Mths Year Ending |
12 Mar-14 |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
5-Yr Chart Click to enlarge
|
---|
ALEMBIC EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 18 | 70 | 53 | 46 | 72 | |
Low | Rs | 7 | 16 | 29 | 32 | 34 | |
Sales per share (Unadj.) | Rs | 5.8 | 5.4 | 4.7 | 5.3 | 4.7 | |
Earnings per share (Unadj.) | Rs | 1.1 | 4.0 | 8.8 | 5.4 | 6.1 | |
Diluted earnings per share | Rs | 0.5 | 1.9 | 4.2 | 2.6 | 2.9 | |
Cash flow per share (Unadj.) | Rs | 1.2 | 4.2 | 9.0 | 5.6 | 6.2 | |
Dividends per share (Unadj.) | Rs | 0.15 | 0.15 | 0.15 | 0.20 | 0.20 | |
Adj. dividends per share | Rs | 0.07 | 0.07 | 0.07 | 0.10 | 0.10 | |
Dividend yield (eoy) | % | 1.2 | 0.3 | 0.4 | 0.5 | 0.4 | |
Book value per share (Unadj.) | Rs | 8.6 | 19.8 | 27.7 | 34.1 | 40.7 | |
Adj. book value per share | Rs | 4.2 | 9.5 | 13.4 | 16.5 | 19.6 | |
Shares outstanding (eoy) | m | 267.03 | 267.03 | 267.03 | 267.03 | 267.03 | |
Bonus/Rights/Conversions | B1:1 | - | - | - | - | ||
Price / Sales ratio | x | 2.1 | 8.0 | 8.7 | 7.5 | 11.3 | |
Avg P/E ratio | x | 11.2 | 10.8 | 4.7 | 7.2 | 8.7 | |
P/CF ratio (eoy) | x | 10.4 | 10.2 | 4.6 | 7.0 | 8.5 | |
Price / Book Value ratio | x | 1.4 | 2.2 | 1.5 | 1.2 | 1.3 | |
Dividend payout | % | 13.6 | 3.8 | 1.7 | 3.7 | 3.3 | |
Avg Mkt Cap | Rs m | 3,298 | 11,469 | 10,962 | 10,521 | 14,139 | |
No. of employees | `000 | NA | NA | NA | NA | NA | |
Total wages/salary | Rs m | 273 | 270 | 238 | 228 | 207 | |
Avg. sales/employee | Rs Th | NM | NM | NM | NM | NM | |
Avg. wages/employee | Rs Th | NM | NM | NM | NM | NM | |
Avg. net profit/employee | Rs Th | NM | NM | NM | NM | NM |
ALEMBIC INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,536 | 1,439 | 1,260 | 1,403 | 1,255 | |
Other income | Rs m | 158 | 208 | 264 | 310 | 370 | |
Total revenues | Rs m | 1,694 | 1,647 | 1,524 | 1,713 | 1,625 | |
Gross profit | Rs m | 223 | 95 | 83 | 67 | 111 | |
Depreciation | Rs m | 23 | 60 | 61 | 51 | 38 | |
Interest | Rs m | 23 | 8 | 0 | 2 | 2 | |
Profit before tax | Rs m | 335 | 235 | 285 | 324 | 442 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 825 | 2,096 | 1,179 | 1,212 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | -32 | -58 | 0 | |
Tax | Rs m | 39 | -7 | 6 | -9 | 24 | |
Profit after tax | Rs m | 295 | 1,066 | 2,343 | 1,454 | 1,630 | |
Gross profit margin | % | 14.5 | 6.6 | 6.6 | 4.8 | 8.9 | |
Effective tax rate | % | 11.8 | -2.9 | 2.1 | -2.6 | 5.4 | |
Net profit margin | % | 19.2 | 74.1 | 185.9 | 103.6 | 129.8 |
ALEMBIC BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,543 | 1,609 | 1,689 | 1,913 | 1,867 | |
Current liabilities | Rs m | 907 | 533 | 486 | 683 | 591 | |
Net working cap to sales | % | 41.4 | 74.8 | 95.4 | 87.6 | 101.6 | |
Current ratio | x | 1.7 | 3.0 | 3.5 | 2.8 | 3.2 | |
Inventory Days | Days | 248 | 214 | 217 | 132 | 94 | |
Debtors Days | Days | 66 | 122 | 81 | 56 | 74 | |
Net fixed assets | Rs m | 1,800 | 1,715 | 1,624 | 1,716 | 1,791 | |
Share capital | Rs m | 534 | 534 | 534 | 534 | 534 | |
"Free" reserves | Rs m | 874 | 3,839 | 5,960 | 8,580 | 10,324 | |
Net worth | Rs m | 2,307 | 5,278 | 7,404 | 9,114 | 10,858 | |
Long term debt | Rs m | 331 | 354 | 104 | 18 | 41 | |
Total assets | Rs m | 3,562 | 6,192 | 8,010 | 9,924 | 11,591 | |
Interest coverage | x | 15.4 | 29.3 | 950.7 | 203.8 | 260.9 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.4 | 0.2 | 0.2 | 0.1 | 0.1 | |
Return on assets | % | 8.9 | 17.4 | 29.3 | 14.7 | 14.1 | |
Return on equity | % | 12.8 | 20.2 | 31.6 | 16.0 | 15.0 | |
Return on capital | % | 13.6 | 19.0 | 31.3 | 15.8 | 15.2 | |
Exports to sales | % | 7.7 | 14.3 | 2.9 | 0.7 | 1.5 | |
Imports to sales | % | 3.4 | 2.5 | 28.9 | 25.4 | 21.0 | |
Exports (fob) | Rs m | 118 | 205 | 37 | 10 | 19 | |
Imports (cif) | Rs m | 52 | 37 | 364 | 356 | 263 | |
Fx inflow | Rs m | 118 | 205 | 37 | 10 | 19 | |
Fx outflow | Rs m | 63 | 42 | 365 | 357 | 264 | |
Net fx | Rs m | 55 | 163 | -328 | -346 | -244 |
ALEMBIC CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -102 | 220 | 346 | 516 | 236 | |
From Investments | Rs m | 178 | 47 | -48 | -467 | -224 | |
From Financial Activity | Rs m | -79 | -250 | -301 | -50 | -27 | |
Net Cashflow | Rs m | -3 | 17 | -3 | 0 | -15 |
Share Holding
|
Company Information
|
CHM: Chirayu R. Amin (MD) | COMP SEC: Chirag K. Shukla | YEAR OF INC: 1907 | BSE CODE: 506235 | FV (Rs): 2 | DIV YIELD (%): 0.1 |
More Pharmaceuticals Company Fact Sheets: PIRAMAL ENTERPRISES NOVARTIS FULFORD INDIA STRIDES PHARMA SCIENCE NATCO PHARMA
Compare ALEMBIC With: PIRAMAL ENTERPRISES NOVARTIS FULFORD INDIA STRIDES PHARMA SCIENCE NATCO PHARMA
Compare ALEMBIC With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.
For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.
For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More